AMPHASTAR PHARMACEUTICALS IN (AMPH)

US03209R1032 - Common Stock

45.46  +0.91 (+2.04%)

After market: 45.46 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
437.8M
25.16%		499M
13.98%		644.395M
29.14%		755.44M
17.23%
EBITDA
YoY % growth
93.39M
187.09%		132.74M
42.14%		237.722M
79.09%		305.18M
28.38%
EBIT
YoY % growth
69.9M
535.45%		107.5M
53.79%		199.687M
85.76%		273.07M
36.75%
Operating Margin
15.97%21.54%30.99%36.15%
EPS
YoY % growth
1.36
112.50%		1.97
44.85%		3.30
67.51%		4.04
22.52%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.99
11.97%
Revenue
Q2Q % growth		196.55M
10.36%
EBITDA
Q2Q % growth		82.266M
-10.60%
EBIT
Q2Q % growth		67.166M
24.43%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 0.96
-16.52%		1.01-0.05-4.74%
Q2 2024
Q2Q % growth		 0.94
44.62%		0.790.1519.17%
Q1 2024
Q2Q % growth		 1.04
67.74%		0.980.066.52%
Q4 2023
Q2Q % growth		 0.88
20.55%		0.94-0.06-6.79%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 191.214M
5.90%		198.59M-7.376M-3.71%
Q2 2024
Q2Q % growth		 182.394M
25.17%		174.36M8.034M4.61%
Q1 2024
Q2Q % growth		 171.836M
22.72%		177.51M-5.674M-3.20%
Q4 2023
Q2Q % growth		 178.105M
31.93%		179M-895K-0.50%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.7% 0.7% -0.12% 5.9%
Revenue-6.49% -6.49% -0.68% -0.83%